ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional Results available

Cabozantinib S-malate and Nivolumab in Treating Patients With Advanced, Recurrent, or Metastatic Endometrial Cancer

ClinicalTrials.gov ID: NCT03367741

Public ClinicalTrials.gov record NCT03367741. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 8:11 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized Phase 2 Study of Cabozantinib in Combination With Nivolumab in Advanced, Recurrent Metastatic Endometrial Cancer

Study identification

NCT ID
NCT03367741
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
National Cancer Institute (NCI)
NIH
Enrollment
82 participants

Conditions and interventions

Interventions

  • Biopsy Procedure Procedure
  • Biospecimen Collection Procedure
  • Cabozantinib S-malate Drug
  • Computed Tomography Procedure
  • Magnetic Resonance Imaging Procedure
  • Nivolumab Biological

Procedure · Drug · Biological

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 15, 2018
Primary completion
May 8, 2025
Completion
Jul 22, 2026
Last update posted
Apr 28, 2026

2018 – 2026

United States locations

U.S. sites
33
U.S. states
17
U.S. cities
28
Facility City State ZIP Site status
Mayo Clinic Hospital in Arizona Phoenix Arizona 85054
Mayo Clinic in Arizona Scottsdale Arizona 85259
City of Hope Comprehensive Cancer Center Duarte California 91010
UC San Diego Moores Cancer Center La Jolla California 92093
Los Angeles General Medical Center Los Angeles California 90033
USC / Norris Comprehensive Cancer Center Los Angeles California 90033
University of California Davis Comprehensive Cancer Center Sacramento California 95817
University of Florida Health Science Center - Gainesville Gainesville Florida 32610
Moffitt Cancer Center Tampa Florida 33612
Northwestern University Chicago Illinois 60611
University of Chicago Comprehensive Cancer Center Chicago Illinois 60637
UC Comprehensive Cancer Center at Silver Cross New Lenox Illinois 60451
University of Chicago Medicine-Orland Park Orland Park Illinois 60462
University of Kansas Clinical Research Center Fairway Kansas 66205
Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore Maryland 21287
Dana-Farber Cancer Institute Boston Massachusetts 02215
Mayo Clinic in Rochester Rochester Minnesota 55905
Siteman Cancer Center at Saint Peters Hospital City of Saint Peters Missouri 63376
Siteman Cancer Center at West County Hospital Creve Coeur Missouri 63141
Washington University School of Medicine St Louis Missouri 63110
Siteman Cancer Center-South County St Louis Missouri 63129
Siteman Cancer Center at Christian Hospital St Louis Missouri 63136
Rutgers Cancer Institute of New Jersey New Brunswick New Jersey 08903
Laura and Isaac Perlmutter Cancer Center at NYU Langone New York New York 10016
Ohio State University Comprehensive Cancer Center Columbus Ohio 43210
Thomas Jefferson University Hospital Philadelphia Pennsylvania 19107
University of Pittsburgh Cancer Institute (UPCI) Pittsburgh Pennsylvania 15232
Parkland Memorial Hospital Dallas Texas 75235
UT Southwestern/Simmons Cancer Center-Dallas Dallas Texas 75390
Huntsman Cancer Institute/University of Utah Salt Lake City Utah 84112
University of Virginia Cancer Center Charlottesville Virginia 22908
VCU Massey Comprehensive Cancer Center Richmond Virginia 23298
University of Wisconsin Carbone Cancer Center - University Hospital Madison Wisconsin 53792

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03367741, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 28, 2026 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03367741 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →